1. Belch, J. J. F., Greer, I., McLaren, M., Saniabadi, A. R., Miller, S., Sturrock, R. D., andForbes, C. D., 1984, The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers.Prostaglandins,28, 67–77.
2. Casals-Stenzel, J., Buse, M., andLosert, W., 1983, Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.Prostaglandins Leukotrienes and Medicine,10, 197–212.
3. De Gaetano, G., Vermylen, J., andVerstraete, M., 1973, A simple indirect method to evaluate platelet aggregation. The clot retraction inhibition (CRI) test.Thrombosis et Diathesis Haemorragica (Stuttg.),29, 661–670.
4. Donati, M. B., Davidson, J. F., andGarattini, S., 1981,Malignancy and the Hemostatic System (New York: Raven Press).
5. Donati, M. B., Poggi, A., Mussoni, L., de Gaetano, G., andGarattini, S., 1977, Hemostasis and experimental cancer dissemination. In:Cancer Invasion and Metastasis: Biological Mechanism and Therapy edited by S. B. Day, W. P. L. Myers, P. Stansley, S. Garattini and M. G. Lewis (New York: Raven Press), pp. 151–160.